Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers

by Alix Morel, Pierre Lebard, Alexandra Dereux, Alexandra Dereux, Alexandra Dereux, Julien Azuar, Julien Azuar, Julien Azuar, Frank Questel, Frank Questel, Frank Questel, Frank Bellivier, Frank Bellivier, Frank Bellivier, Frank Bellivier, Cynthia Marie-Claire, Cynthia Marie-Claire, Mélina Fatséas, Mélina Fatséas, Mélina Fatséas, Florence Vorspan, Florence Vorspan, Florence Vorspan, Florence Vorspan, Vanessa Bloch, Vanessa Bloch, Vanessa Bloch
Published 2021-02-01